Nestle India (NESTLEIND) — Financial Results

1 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Nestlé India reported Q3 FY2024-25 revenue of ₹4,762 crores with 3.9% YoY growth despite inflationary headwinds. Nine-month profit reached ₹2,967 crores. The company declared a second interim dividend of ₹14.25 per share, bringing total FY25 dividends to ₹17 per share. Key drivers include beverage segment high double-digit growth, e-commerce expansion at 9.1% of domestic sales, and petcare achieving highest growth since 2022 integration. Cost pressures persist with material costs at 43.8% of sales. Strategic moves include NESPRESSO market entry and 49% investment in Dr. Reddy's nutraceutical joint venture.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Nestlé India reported Q3 FY2024-25 total sales of ₹4,762.1 crores, growing 3.9% YoY, driven by beverages (NESCAFÉ surpassed ₹2,000 crore retail sales) and KITKAT's double-digit performance. Net profit reached ₹696.1 crores. The board declared a second interim dividend of ₹14.25 per share (total ₹137.4 crores), following the first dividend of ₹2.75. Material costs increased to 43.8% of sales from 41.6% prior year. Exceptional gains from nutraceutical business slump sale and a 49% investment in Dr. Reddy's joint venture were recorded.

📊 Stock Analysis — NESTLEIND ✨ Ask AI About This

About Nestle India Limited (NESTLEIND)

Fast Moving Consumer Goods · Food Products · Listed on NSE

Market Cap: ₹2,75,845.36 Cr P/E: 84.6 ROE: 81.3% ROCE: 93.6%

View full NESTLEIND stock details →

📡 Get AI alerts when NESTLEIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NESTLEIND — Free

💡 Ask AI about this filing

"How does this financial results affect Nestle India Limited's outlook?" "What did Nestle India Limited announce on 31 January 2025?" "Is this positive or negative for NESTLEIND?"

Ask AI Free →

📊 More NESTLEIND filings

See all NESTLEIND filings →

🔥 Also filed on 31 January 2025

SUNPHARMA Sun Pharmaceutical Industries Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results TATACONSUM TATA CONSUMER PRODUCTS LIMITED Financial Results SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NESTLEIND files new disclosures

Track NESTLEIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.